BioHealth News Archive
How Scientists 3D Printed a Tiny Heart from Human Cells
It has four chambers, blood vessels and it beats — sort of. In a first, scientists have 3D printed a heart using human tissue.…
Read More
Viela Bio Receives U.S. FDA Breakthrough Therapy Designation for Inebilizumab for Treatment of Neuromyelitis Optica Spectrum Disorder | Business Wire
Viela Bio today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for the Company’s anti-CD19 monoclonal antibody…
Read More
Washington, DC ranked #1 Most Talent Competitive Cities – INSEAD Knowledge
If asked “What’s the most talent competitive city in the U.S.?” few Americans would name the top of our global list: Washington, D.C. (1).…
Read More
HHS Seeks to Spur Breakthroughs in Treating Kidney Disease – Nextgov
A nascent project launched by the Health and Human Services Department aims to spur innovation and help solve an expensive health crisis plaguing millions…
Read More
Top Five Stem Cell Companies to Watch in the BioHealth Capital Region - BioBuzz
The BioHealth Capital Region (BHCR) is rapidly becoming an industry hub for companies that are developing next-generation therapeutics that focus on personalized and regenerative…
Read More
Principal Gift From United Arab Emirates To Support Development Of Children’s National Research & Innovation Campus
Children's National today announced a $30 million gift from the United Arab Emirates (UAE), marking a major milestone in the creation of its new…
Read More
First 3D Engineered Vascularized Human Heart Is Bioprinted
Scientists at Tel Aviv University (TAU) have printed the world’s first 3D vascularized engineered heart using a patient’s own cells and biological materials. Their…
Read More
JLABS @ Washington, DC Children’s QuickFire Challenge | JLABS
In honor of the new JLABS @ Washington, DC – a 32,000 square foot facility located on the new Children’s National Research and Innovation…
Read More
Emergent BioSolutions Announces Interim Results From Phase 2 Study Evaluating CHIKV-VLP, Chikungunya Virus Vaccine Candidate NYSE:EBS
Emergent BioSolutions Inc. (NYSE:EBS) today announced results from the interim analysis of its Phase 2 clinical study evaluating the safety and immunogenicity of the…
Read More
Paragon Bioservices Celebrates Grand Opening of its World-Class Gene Therapy Biomanufacturing Facility – Paragon Bioservices, Inc.
Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, celebrated this…
Read More
Startup Professionals Musings: 7 Steps For Assuring Business Success And Fulfillment
Is it possible to be successful in business and not fulfilled? The answer is a resounding yes today, and I’m convinced that it will…
Read More
Catalent To Acquire Gene Therapy Leader Paragon Bioservices, Inc. For $1.2 Billion
Catalent, Inc. (NYSE: CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, and…
Read More
Virginia Tech’s Innovation Campus To Spawn New Patent Ecosystem In Northern Virginia – Intellectual Property – United States
In mid-November 2018, Amazon grabbed headlines when it announced it will build part of its new headquarters in Northern Virginia.1 The site for HQ2…
Read More
QIAGEN Launches First FDA-Approved Companion Diagnostic Using FGFR Alterations to Help Guide the Treatment of Metastatic Urothelial Cancer | BioSpace
QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced the U.S. launch of its novel therascreen® FGFR RGQ RT-PCR Kit (therascreen FGFR Kit) as a…
Read More
After ending 2018 strong, DC venture capital funding totals fell to start 2019 – Technical.ly DC
For a second year in a row, D.C. metro area venture capital funding in the first quarter dropped when compared to the previous quarter.…
Read More